EpidStrategies participating in ASH 2020
EpidStrategies, a division of ToxStrategies is excited to be participating in the American Society of Hematology Annual Meeting, which will be held virtually on December… read more
Latest News
EpidStrategies Scientist on Leadership Panel
Dr. Naushin Hooda, an EpidStrategies Doctor of Pharmacy based in Toronto, will participate in a virtual panel discussion as part of the Canadian… read more
ICPE — 35 Years of Real-World Science
EpidStrategies scientists, including Dr. Jon Fryzek, Ms. Mina Suh, Ms. Heidi Reichert, Ms. Lauren Bylsma, Dr. Sarah Cohen, Ms. Xiaohui Jiang, and Ms…. read more
EpidStrategies and ToxStrategies review essential elements for a successful orphan drug program
EpidStrategies scientists have collaborated with toxicologists from ToxStrategies’ Biopharmaceuticals/Pharmaceuticals Practice to produce a white paper that provides “Critical insights into nonclinical toxicology and… read more
EpidStrategies scientists present at ESMO virtual meeting
The European Society for Medical Oncology (ESMO) Academy has gone virtual for 2020, and Ms. Naimisha Movva and Dr. Jon Fryzek will present… read more
New opening for an Epidemiologist
EpidStrategies, a division of ToxStrategies, Inc., has opened a position for an epidemiologist to join our team of epidemiologists and statisticians conducting systematic… read more
EpidStrategies scientists at rare-disease summit
EpidStrategies epidemiologists Dr. Jon Fryzek and Ms. Lauren Bylsma will present a poster at the “Rare Diseases and Orphan Products Breakthrough Summit,” to… read more
EpidStrategies scientists attend ICPE
Scientists from EpidStrategies, a Division of ToxStrategies, presented at the 35th International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE). The August 2019… read more